Ryan Fink
![](https://stratcann.com/wp-admin/admin-ajax.php?action=kernel&p=image&src=%7B%22file%22%3A%22wp-content%2Fuploads%2F2023%2F10%2Fimages_large_ao3c04496_0009.jpeg%22%2C%22thumbnail%22%3A%22760%2C540%2C%22%7D&hash=9495173d)
New research suggests that the effect of terpenes on cannabis aroma is overhyped
A study published recently in the America Chemical Society’s (ACS) journal Omega suggests that terpenes are only part of the picture when determining what compounds…
![](/wp-content/themes/yootheme/cache/6b/week-in-weed-feature-6b9cc6cb.jpeg)
Week in Weed – October 28, 2023
StratCann’s weekly round-up of news headlines in the cannabis industry for the week ending October 28, 2023.
![](https://stratcann.com/wp-admin/admin-ajax.php?action=kernel&p=image&src=%7B%22file%22%3A%22wp-content%2Fuploads%2F2023%2F05%2Fno-significant-change-cannabis-use-disorder.jpg%22%2C%22thumbnail%22%3A%22760%2C540%2C%22%7D&hash=cb47c586)
New cannabis study shows no significant change in rates of use-disorder post-legalization
Despite fears that legalizing cannabis would lead to troubling increases in problematic cannabis use, a new study is once again showing these concerns were over-hyped.
![](/wp-content/themes/yootheme/cache/a1/Cannabis-Lab-Testing-THC-Canada-a1c8ffb0.jpeg)
More changes needed to address inflated THC levels
Early last December I penned an article for StratCann voicing my hope that Health Canada’s freshly announced allowance of the production and sale of new…
![](/wp-content/themes/yootheme/cache/b3/lab-testing-thc-canada-feature-b3aff1c2.png)
New testing standards could help challenge inflated THC levels in legal weed
Last Friday, Health Canada announced several changes to the cannabis regulations. While a long-awaited change to beverage equivalency factors is getting most of the attention,…